March 30, 2015 — The Medicines Company announced that the European Commission has granted marketing authorization for ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 30, 2015
March 30, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new ...
March 30, 2015March 25, 2015 — Adding the antiplatelet drug ticagrelor (Brilinta) to aspirin as long-term therapy after a heart attack ...
March 26, 2015March 15, 2015 — A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more ...
March 25, 2015March 24, 2015 — Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug ...
March 24, 2015
March 19, 2015 — Data from a meta-analysis published recently in The Lancet found that extended-duration dual ...
March 19, 2015
March 16, 2015 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman ...
March 16, 2015March 13, 2015 — Researchers at the University of North Carolina (UNC) School of Medicine have found the blood platelet ...
March 13, 2015
March 11, 2015 — Point of Care Anticoagulation software (PCDS AC) optimizes delivery of anticoagulation (AC) drugs and ...
March 11, 2015
March 9, 2015 — Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take bl ...
March 09, 2015March 6, 2015 — Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist ...
March 06, 2015
March 4, 2015 — The U.S. Food and Drug Administration (FDA) has approved the Xarelto Starter Pack for deep vein ...
March 04, 2015February 26, 2015 — Nanometer-sized “drones” could become a new way to prevent heart attacks caused by atherosclerosis ...
February 26, 2015February 26, 2015 — Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux ...
February 26, 2015
February 26, 2015 — By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston ...
February 26, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now